UPDATE 2-Pfizer swings to quarterly loss due to COVID products write-off
Published
Pfizer on Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its COVID products such as its antiviral treatment Paxlovid and vaccine Comirnaty. Paxlovid sales slumped 97% in the quarter to $202 million, while vaccine revenue came…
#comirnaty #pfizer